Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: Systematic review and meta-analysis. Eur Urol 2005;48 : 386-99 - Reply to C. Stephan, D. Schnorr, S.A. Loening, K. Jung

Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: Systematic review and meta-analysis. Eur Urol 2005;48 : 386-99 - Reply to C. Stephan, D. Schnorr, S.A. Loening, K. Jung

Bibliographische Detailangaben
Hauptverfasser:	Roddam, A, Allen, N
Format:	Journal article
Veröffentlicht:	2005

Ähnliche Einträge

Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99.
von: Stephan, C, et al.
Veröffentlicht: (2005)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
von: Amit M. Algotar PhD, MBBS, et al.
Veröffentlicht: (2011-05-01)

Accuracy assessment of PSA methods must be based on clinical instead of artificial samples - a response to AW Roddam et al., Ann Clin Biochem 2006;43 : 35-48 - Reply
von: Roddam, A, et al.
Veröffentlicht: (2006)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
von: Törnblom, M, et al.
Veröffentlicht: (2001)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
von: Mohammad Yazdani, et al.
Veröffentlicht: (2013-10-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
von: Sävblom, C, et al.
Veröffentlicht: (2009)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
von: Daniel Simanjuntak, et al.
Veröffentlicht: (2016-03-01)

Utility of PSA isoform-[-2] proPSA (p2PSA) and prostate health index in the diagnosis of prostate cancer: A study in Indian population
von: Govinda Raju NL, et al.
Veröffentlicht: (2022-01-01)

Free PSA and prostate volume on the diagnosis of prostate carcinoma
von: Antonio Carlos Pereira Martins, et al.
Veröffentlicht: (2003-01-01)

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
von: Roddam, A, et al.
Veröffentlicht: (2005)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
von: Sävblom, C, et al.
Veröffentlicht: (2005)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
von: Blijenberg, BG, et al.
Veröffentlicht: (2003)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
von: Strittmatter F, et al.
Veröffentlicht: (2011-10-01)

Age-specific reference intervals for Prostate-Specific-Antigen (PSA), its isoform-[-2] pro-PSA (p2PSA) and prostate health index in Indian males
von: Govinda Raju NL, et al.
Veröffentlicht: (2024-04-01)

Prostate cancer: estimating the benefits of PSA screening.
von: Vickers, A, et al.
Veröffentlicht: (2009)

Prostate cancer recurrence in the urethra with low PSA
von: Shravankrishna Ananthapadmanabhan, et al.
Veröffentlicht: (2024-07-01)

Prostate Specific Antigen (PSA): The Historical Perspective
von: T. Ming Chu
Veröffentlicht: (2020-12-01)

Histomorphologic Correlation of PSA Levels in Prostatic Pathology
von: Deepak Panasseril Jayapradeep, et al.
Veröffentlicht: (2017-10-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
von: Tsung-Hsin Chang, et al.
Veröffentlicht: (2020-10-01)

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
von: Yiji Peng, et al.
Veröffentlicht: (2025-03-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
von: Murat Zor, et al.
Veröffentlicht: (2018-12-01)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
von: Hyungseok Cho, et al.
Veröffentlicht: (2022-03-01)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
von: Emerson P. Gregorio, et al.
Veröffentlicht: (2007-04-01)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
von: , DAHESIHDEWI, Andaru, et al.
Veröffentlicht: (2002)

Malakoplakia of the prostate diagnosed by elevated PSA level and transrectal prostate biopsy
von: Sacit Nuri Görgel, et al.
Veröffentlicht: (2011-04-01)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
von: Priya Duvedi, et al.
Veröffentlicht: (2019-05-01)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
von: Mehmet Coşkun, et al.
Veröffentlicht: (2021-02-01)

AGE, TOTAL PSA, PSA DENSITY AND GLEASON SCORE, TAUS AS PREDICTIVE FACTORS IN PATIENTS WITH PROSTATE CANCER
von: Daruqutni Albar, et al.
Veröffentlicht: (2016-03-01)

Incidence of histological prostatitis and its correlation with PSA density
von: Affonso Celso Piovesan, et al.
Veröffentlicht: (2009-11-01)

Metastatic prostate cancer in the modern era of PSA screening
von: Philip A. Fontenot Jr, et al.

PSA testing for men at average risk of prostate cancer
von: Bruce K Armstrong, et al.
Veröffentlicht: (2017-07-01)

THE INCIDENCE AND CORRELATION OF CHRONIC PROSTATITIS WITH PSA IN BPH PATIENT
von: Daniel Mahendra Krisna, et al.
Veröffentlicht: (2018-07-01)

Autopsy prostate cancer: Pre and post PSA era
von: R Kumar, et al.
Veröffentlicht: (2006-01-01)

Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer.
von: Lilja, H
Veröffentlicht: (2001)

Clinical application of p2PSA and its derivatives (%p2PSA and Phi) in the diagnosis of prostate cancer
von: Weiwang Cai, et al.
Veröffentlicht: (2023-11-01)

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
von: O. Üçer, et al.
Veröffentlicht: (2017-06-01)

Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activity.
von: Johanna M Mattsson, et al.
Veröffentlicht: (2014-01-01)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml−1
von: Ma-Ping Huang, et al.
Veröffentlicht: (2023-01-01)

Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
von: Kurek, R, et al.
Veröffentlicht: (2003)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
von: A. A. Gritskevich, et al.
Veröffentlicht: (2017-02-01)